# Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas

> **NCT01140568** · PHASE2 · COMPLETED · sponsor: **David Piccioni, M.D., Ph.D** · enrollment: 38 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** nilotinib

## Key facts

- **NCT ID:** NCT01140568
- **Lead sponsor:** David Piccioni, M.D., Ph.D
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04-21
- **Primary completion:** 2016-10-05
- **Final completion:** 2019-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2020-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01140568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01140568, "Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01140568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*